Integrated health economics and market access services for the pharmaceutical industry

DRG Abacus provide integrated health economics and outcomes research (HEOR), and market access services to global pharmaceutical product development organisations. We balance scientific rigour with commercial awareness, and are recognised in the health economics and market access space for our innovation, technical excellence, creativity, and design. Our in-depth experience covers strategic and tactical support for evidence generation and implementation, and value communication across all disease areas.

We are pioneers in evidence-based market access solutions and we partner with pharmaceutical product development teams over the lifecycle of the brand to facilitate the development and communication of evidence-based value externally and internally. Our services support global teams and local market affiliates to prepare for the critical aspects of market access, including health technology assessment and local reimbursement at all key stages, from early phase to post-launch.

Our vision

Our vision is to work in partnership with our clients to provide flexible, solution focused HEOR evidence generation and implementation activities that ensure pharmaceutical product development teams secure successful market access for their healthcare interventions.

Comprehensive, integrated global products and services

Our health economics and market access products and services support pharmaceutical, biotech, and medical device companies with:

We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.

DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.

Our Company
© DRG Abacus 2019